Tocilizumab: a novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases.

@article{Alten2013TocilizumabAN,
  title={Tocilizumab: a novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases.},
  author={Rieke E Alten and Tazio Maleitzke},
  journal={Annals of medicine},
  year={2013},
  volume={45 4},
  pages={357-63}
}
Tocilizumab is a highly effective therapeutic agent for the treatment of rheumatoid arthritis and systemic juvenile idiopathic arthritis. Furthermore, a large amount of case study data reveals that tocilizumab can be an effective therapy for not only rheumatoid arthritis but also for other mostly rare inflammatory rheumatic diseases. By blocking the interleukin-6 pathway tocilizumab can be a useful therapeutic alternative when conventional treatment fails. It is successful in treating diseases… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 4 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

Treat-to-target in systemic lupus erythematosus: are we there yet?

Expert review of clinical pharmacology • 2016
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 53 references

Effi cacy and safety of Tocilizumab ( TCZ ) in patients with systemic juvenile idiopathic arthritis ( sJIA ) : 2 - year data from TENDER , a phase 3 clinical trial

F DeBenedetti, H Brunner, +3 authors I Calvo
Ann Rheum Dis • 2012

Tocilizumab improves cardiac disease in a hemodialysis patient with AA amyloidosis secondary to rheumatoid arthritis.

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis • 2012

spondylitis in patients refractory to TNF-inhibition: are there alterna- tives

C Salvarani, F Cantini, L Boiardi
Curr Opin Rheumatol • 2012

Similar Papers

Loading similar papers…